NGF withdrawal induces apoptosis in CESS B cell line through p38 MAPK activation and Bcl-2 phosphorylation

被引:43
作者
Rosini, P [1 ]
De Chiara, G
Lucibello, M
Garaci, E
Cozzolino, F
Torcia, M
机构
[1] Univ Florence, Dept Clin Physiopathol, Florence, Italy
[2] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Rome, Italy
[3] Natl Res Council, Inst Expt Med, Rome, Italy
关键词
apoptosis; nerve growth factor; p38; MAPK; lymphoblastoid cells; Bcl-2; phosphorylation;
D O I
10.1006/bbrc.2000.3871
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The sIgG(+) lymphoblastoid B cell line CESS spontaneously produces a high amount of NGF and expresses both high affinity (p140(Trk-A)) and low affinity (p75(NTR)) NGF receptors. Blocking NGF signals with neutralizing antibodies or specific Trk-A inhibitors induces a rapid phosphorylation of antiapoptotic Bcl-2 protein, followed by caspase activation, and apoptotic death of CESS cells. Bcl-2 phosphorylation in several sites within a approximate to 60 aa "loop" domain of protein is known to regulate its antiapoptotic function. Accordingly, CESS cells expressing the loop deletional mutant cDNA constructs Bcl-2 Delta 40-91 were completely resistant to apoptosis induced by NGF withdrawal, indicating that Bcl-2 phosphorylation is a critical event. NGF withdrawal induces p38 MAPK, but not JNK, activation in CESS cells, and SB203580, a specific inhibitor of p38 MAPK, is able to prevent both Bcl-2 phosphorylation and apoptosis, indicating that p38 MAPK is the enzyme responsible for these events. (C) 2000 Academic Press.
引用
收藏
页码:753 / 759
页数:7
相关论文
共 33 条
[1]   Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator [J].
Brenner, C ;
Cadiou, H ;
Vieira, HLA ;
Zamzami, N ;
Marzo, I ;
Xie, ZH ;
Leber, B ;
Andrews, D ;
Duclohier, H ;
Reed, JC ;
Kroemer, G .
ONCOGENE, 2000, 19 (03) :329-336
[2]   Nerve growth-factor and anti-CD40 provide opposite signals for the production of IgE in interleukin-4-treated lymphocytes [J].
Brodie, C ;
Oshiba, A ;
Renz, H ;
Bradley, K ;
Gelfand, EW .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (01) :171-178
[3]   Identification of a novel regulatory domain in Bcl-x(L) and Bcl-2 [J].
Chang, BS ;
Minn, AJ ;
Muchmore, SW ;
Fesik, SW ;
Thompson, CB .
EMBO JOURNAL, 1997, 16 (05) :968-977
[4]   BCL-2 FAMILY: Regulators of cell death [J].
Chao, DT ;
Korsmeyer, SJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :395-419
[5]   Conversion of Bcl-2 to a Bax-like death effector by caspases [J].
Cheng, EHY ;
Kirsch, DG ;
Clem, RJ ;
Ravi, R ;
Kastan, MB ;
Bedi, A ;
Ueno, K ;
Hardwick, JM .
SCIENCE, 1997, 278 (5345) :1966-1968
[6]   Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: A link between the apoptosome and the proteasome pathway [J].
Dimmeler, S ;
Breitschopf, K ;
Haendeler, J ;
Zeiher, AM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (11) :1815-1822
[7]   Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells [J].
Fadeel, B ;
Hassan, Z ;
Hellström-Lindberg, E ;
Henter, JI ;
Orrenius, S ;
Zhivotovsky, B .
LEUKEMIA, 1999, 13 (05) :719-728
[8]   All along the watchtower: on the regulation of apoptosis regulators [J].
Fadeel, B ;
Zhivotovsky, B ;
Orrenius, S .
FASEB JOURNAL, 1999, 13 (13) :1647-1657
[9]   Vinblastine-induced phosphorylation of Bcl-2 and Bcl-XL is mediated by JNK and occurs in parallel with inactivation of the Raf-1/MEK/ERK cascade [J].
Fan, MY ;
Goodwin, M ;
Vu, T ;
Brantley-Finley, C ;
Gaarde, WA ;
Chambers, TC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (39) :29980-29985
[10]   ROLE OF BCL-2 IN THE SURVIVAL AND FUNCTION OF DEVELOPING AND MATURE SYMPATHETIC NEURONS [J].
GREENLUND, LJS ;
KORSMEYER, SJ ;
JOHNSON, EM .
NEURON, 1995, 15 (03) :649-661